• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

A novel anti-HMGB1 Ab therapy for treatment of B-cell lymphoma

Research Project

  • PDF
Project/Area Number 20590539
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Applied pharmacology
Research InstitutionOkayama University

Principal Investigator

TAKAHASHI Hideo  Okayama University, 大学院・医歯薬学総合研究科, 准教授 (60335627)

Co-Investigator(Kenkyū-buntansha) NISHIBORI Masahiro  岡山大学, 大学院・医歯薬学総合研究科, 教授 (50135943)
YOSHINO Tasashi  岡山大学, 大学院・医歯薬学総合研究科, 教授 (70183704)
Project Period (FY) 2008 – 2010
KeywordsHMGB1 / RAGE / B細胞リンパ腫 / 単球・マクロファージ / 活性酸素 / 接着分子 / AGE / オータコイド
Research Abstract

A RAGE ligand, HMGB1, which is released from nucrei of necrotic cells and macropharges, acts as a cytokine and plays roles in immune response. HMGB1 is involved in the progression of B-cell limphoma. The progression depends on the monocyte/macropharge activation. RAGE ligands, HMGB1 and AGEs, activates monocyte/macropharge. Therefore, anti-HMGB1 Ab may inhibit the progression of B-cell limphoma.

  • Research Products

    (19 results)

All 2010 2009

All Journal Article (12 results) Presentation (4 results) Patent(Industrial Property Rights) (3 results)

  • [Journal Article] beta(2)-adrenoceptor stimulation inhibits advanced glycation end products-induced adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells.2010

    • Author(s)
      Takahashi HK, Mori S, Liu K, Wake H, Zhang J, Liu R, Yoshino T, Nishibori, M.
    • Journal Title

      Eur J Pharmacol. 627

      Pages: 313-317

  • [Journal Article] Advanced glycation end products enhance monocyte activation during human mixed lymphocyte reaction.2010

    • Author(s)
      Ohashi K, Takahashi HK, Mori S, Liu K, Wake H, Sadamori H, Matsuda H, Yagi T, Yoshino T, Nishibori M, Tanaka N
    • Journal Title

      Clin Immunol 134

      Pages: 345-353

  • [Journal Article] Histamine inhibits advanced glycation end product-induced adhesion molecule expression on monocytes during human mixed lymphocyte reaction2010

    • Author(s)
      Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Sadamori H, Matsuda H, Yagi T , Yoshino T, Mori S, Nishibori M
    • Journal Title

      Br J Pharmacol. 160

      Pages: 1378-1386

  • [Journal Article] Effect of nicotine on advanced glycation end products-induced immune response in human monocytes.2010

    • Author(s)
      Takahashi HK, Liu K, Wake H, Mori S, Zhang J, Liu R, Yoshino T, Nishibori M.
    • Journal Title

      J Pharmacol Exp Ther. 332

      Pages: 1013-1021

  • [Journal Article] Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression on monocytes, cytokine production and lymphocyte proliferation during human mixed lymphocyte reaction.2010

    • Author(s)
      Takahashi HK, Zhang J, Mori S, Liu K, Wake H, Liu R, Sadamori H, Matsuda H, Yagi T, Yoshino T, Nishibori M
    • Journal Title

      J Pharmacol Exp Ther. 334

      Pages: 964-972

  • [Journal Article] High mobility group box 1 complexed with heparin induced angiogenesis in a matrigel plug assay.2009

    • Author(s)
      Wake H, Mori S, Liu K, Takahashi HK, Nishibori M
    • Journal Title

      Acta Med Okayama 63

      Pages: 249-262

  • [Journal Article] Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay.2009

    • Author(s)
      Wake H, Mori S, Liu K, Takahashi HK, Nishibori M
    • Journal Title

      Eur J Pharmacol. 623

      Pages: 89-95

  • [Journal Article] Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation endproducts : heparin's effect on binding.2009

    • Author(s)
      Liu R, Mori S., Wake H, Zhang J, Liu K, Izushi Y, Takahashi HK, Peng B, Nishibori M
    • Journal Title

      Acta Med Okayama 63

      Pages: 203-211

  • [Journal Article] Advanced glycation end products subspecies-selectively induce adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells.2009

    • Author(s)
      Takahashi HK, Mori S, Wake H, Liu K, Yoshino T, Ohashi K, Tanaka N, Shikata K, Makino H, Nishibori M.
    • Journal Title

      J Pharmacol Exp Ther. 330

      Pages: 89-98

  • [Journal Article] Histamine inhibits advanced glycation end products-induced adhesion molecule expression on human monocytes.2009

    • Author(s)
      Wake H, Takahashi HK, Mori S, Liu K, Yoshino T, Nishibori M.
    • Journal Title

      J Pharmacol Exp Ther 330

      Pages: 826-833

  • [Journal Article] Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells.2009

    • Author(s)
      Takahashi HK, Liu K, Wake H, Mori S, Zhang J, Liu R, Yoshino T, Nishibori M.
    • Journal Title

      J Pharmacol Exp Ther. 331

      Pages: 656-670

  • [Journal Article] Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column.2009

    • Author(s)
      Nishibori M, Takahashi HK, Katayama H, Mori S, Saito S, Iwagaki H, Tanaka N, Morita K, Ohtsuka A
    • Journal Title

      Acta Med Okayama. 63

      Pages: 65-69

  • [Presentation] Advanced glycation end products induce adhesion molecule expression and cytokine production in human PBMC2010

    • Author(s)
      高橋英夫, 劉克約, 和氣秀徳, 森秀治, 西堀正洋
    • Organizer
      第14回国際免疫学会
    • Place of Presentation
      神戸
    • Year and Date
      20100822-20100827
  • [Presentation] Prostaglandins E_2 inhibits advanced glycation end products-induced activation of human monocytes2010

    • Author(s)
      高橋英夫, 劉克約, 和氣秀徳, 森秀治, 西堀正洋
    • Organizer
      第16回国際薬理学会
    • Place of Presentation
      コペンハーゲン
    • Year and Date
      20100717-20100723
  • [Presentation] AGE-2とAGE-3誘導性のヒト単球の活性化に対するプロスタグランディンE2の効果2010

    • Author(s)
      高橋英夫, 劉克約, 和氣秀徳, 森秀治, 西堀正洋
    • Organizer
      第83回日本薬理学会年会
    • Place of Presentation
      大阪
    • Year and Date
      20100316-20100318
  • [Presentation]2009

    • Author(s)
      高橋英夫, 森秀治, 劉克約, 和氣秀徳, 西堀正洋
    • Organizer
      第82回日本薬理学会年会
    • Place of Presentation
      横浜
    • Year and Date
      20090316-20090318
  • [Patent(Industrial Property Rights)] 外傷性神経障害治療剤2010

    • Inventor(s)
      西堀正洋、森秀治、高橋英夫、和氣秀徳、劉克約、伊達勲、大熊佑、友野靖子
    • Industrial Property Rights Holder
      西堀正洋、森秀治、高橋英夫、和氣秀徳、劉克約、伊達勲、大熊佑、友野靖子
    • Industrial Property Number
      特許,特願2010-214019
    • Filing Date
      2010-12-23
  • [Patent(Industrial Property Rights)] RAGEとAGEの結合抑制剤のスクリーニング方法2010

    • Inventor(s)
      西堀正洋、森秀治、高橋英夫、和氣秀徳、劉克約
    • Industrial Property Rights Holder
      西堀正洋、森秀治、高橋英夫、和氣秀徳、劉克約
    • Industrial Property Number
      特許,特願2010-214019
    • Filing Date
      2010-09-24
  • [Patent(Industrial Property Rights)] アテローム動脈硬化抑制剤2009

    • Inventor(s)
      西堀正洋,高橋英夫,森秀治,劉克約,友野靖子,ベイカーメディカルリサーチインスティチュート
    • Industrial Property Rights Holder
      西堀正洋,高橋英夫,森秀治,劉克約,友野靖子,ベイカーメディカルリサーチインスティチュート
    • Industrial Property Number
      特許,特願2009-223472
    • Filing Date
      2009-09-28

URL: 

Published: 2012-01-26   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi